Sleep Disorders Trial, Recruiting NCT04817163 Sponsor: CHU de Quebec-Universite Laval Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT04817163
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with cancer that has not spread to other parts of the body (any cancer type)
  • People aged 18 years or older
  • People who can read and understand French or English without difficulty
  • People who have the basic mental ability to read, understand, and remember information
  • People who have access to the internet

Who may not be able to join:

  • People who have a mental health condition that currently requires professional clinical care (for example, major depression)
  • People who have been diagnosed with a serious condition affecting memory or thinking (for example, Parkinson's disease or dementia)
  • People whose sleep problems are caused by a short-term situation (for example, sudden pain, temporary medication side effects, or environmental disruptions)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Josée Savard, Ph.D., Centre de recherche du CHU de Québec-Université Laval

Phone: 418-525-4444

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CHU de Quebec-Universite Laval
Registry
ClinicalTrials.gov
Start date
13 December 2019
Est. completion
30 May 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Implementation (organizational) measures; 1) Change in Insomnia Severity Index Scores; 2) Change in sleep efficiency (SE); 3) Change in sleep onset latency (SOL); 4) Change in wake after sleep onset (WASO); 5) Change in total wake time (TWT); 6) Change in total sleep time (TST); 7) Hospital Anxiety and Depression Scale (HADS); 8) Fatigue Symptom Inventory (FSI); 9) The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30); 10) Satisfaction with Life Scale (SWLS); 1) Psychologists' adherence to the protocol; 2) Psychologists' perceived self-eff...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov